MICONAZOLE 3 COMBINATION PACK Drug Patent Profile
When do Miconazole 3 Combination Pack patents expire, and when can generic versions of Miconazole 3 Combination Pack launch?
Miconazole 3 Combination Pack is a drug marketed by Perrigo and is included in one NDA.
The generic ingredient in MICONAZOLE 3 COMBINATION PACK is miconazole nitrate. There is one drug master file entry for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the miconazole nitrate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Miconazole 3 Combination Pack
A generic version of MICONAZOLE 3 COMBINATION PACK was approved as miconazole nitrate by ACTAVIS PHARMA on November 19th, 1993.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for MICONAZOLE 3 COMBINATION PACK?
- What are the global sales for MICONAZOLE 3 COMBINATION PACK?
- What is Average Wholesale Price for MICONAZOLE 3 COMBINATION PACK?
Summary for MICONAZOLE 3 COMBINATION PACK
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 7 |
| Raw Ingredient (Bulk) Api Vendors: | 101 |
| Clinical Trials: | 33 |
| Patent Applications: | 3,474 |
| DailyMed Link: | MICONAZOLE 3 COMBINATION PACK at DailyMed |
Recent Clinical Trials for MICONAZOLE 3 COMBINATION PACK
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Cairo University | PHASE3 |
| Ain Shams University | Phase 3 |
| Assistance Publique - Hôpitaux de Paris | PHASE2 |
US Patents and Regulatory Information for MICONAZOLE 3 COMBINATION PACK
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Perrigo | MICONAZOLE 3 COMBINATION PACK | miconazole nitrate | CREAM;TOPICAL, VAGINAL | 076357-001 | Mar 30, 2004 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
